标题
Nicotine as a potential neuroprotective agent for Parkinson's disease
作者
关键词
-
出版物
MOVEMENT DISORDERS
Volume 27, Issue 8, Pages 947-957
出版商
Wiley
发表日期
2012-06-12
DOI
10.1002/mds.25028
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Effects of Caffeine in Parkinson's Disease: From Neuroprotection to the Management of Motor and Non-Motor Symptoms
- (2017) Rui D.S. Prediger JOURNAL OF ALZHEIMERS DISEASE
- Environmental and Familial Risk Factors of Parkinsons Disease: Case-Control Study
- (2014) Jaya Sanyal et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- Nicotinic Attenuation of Central Nervous System Inflammation and Autoimmunity
- (2014) F.-D. Shi et al. JOURNAL OF IMMUNOLOGY
- Glia as a Turning Point in the Therapeutic Strategy of Parkinsons Disease
- (2012) Francesca L'Episcopo et al. CNS & Neurological Disorders-Drug Targets
- Reward, Addiction, Withdrawal to Nicotine
- (2011) Mariella De Biasi et al. Annual Review of Neuroscience
- Mechanistic insights into nicotine withdrawal
- (2011) Michael Paolini et al. BIOCHEMICAL PHARMACOLOGY
- Pharmacotherapy for Smoking Cessation
- (2011) Tobias Raupach et al. CNS DRUGS
- Review on the Protective Effects of PACAP in Models of Neurodegenerative Diseases In Vitro and In Vivo
- (2011) D. Reglodi et al. CURRENT PHARMACEUTICAL DESIGN
- Parkinson’s disease risk from ambient exposure to pesticides
- (2011) Anthony Wang et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Epidemiology and etiology of Parkinson’s disease: a review of the evidence
- (2011) Karin Wirdefeldt et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Novel therapy in Parkinson's disease: adenosine A2Areceptor antagonists
- (2011) Nikoletta Szabó et al. Expert Opinion on Drug Metabolism & Toxicology
- Neuroprotection of midbrain dopamine neurons by nicotine is gated by cytoplasmic Ca2+
- (2011) Damien Toulorge et al. FASEB JOURNAL
- Nicotine Reduces L-DOPA-Induced Dyskinesias by Acting at 2* Nicotinic Receptors
- (2011) L. Z. Huang et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes
- (2011) Olivier Rascol et al. LANCET NEUROLOGY
- Modelling of Parkinson's disease in mice
- (2011) Marie-Françoise Chesselet et al. LANCET NEUROLOGY
- Parkinson's disease, proteins, and prions: Milestones
- (2011) C. Warren Olanow et al. MOVEMENT DISORDERS
- A tale on animal models of Parkinson's disease
- (2011) Erwan Bezard et al. MOVEMENT DISORDERS
- Etiology and pathogenesis of Parkinson's disease
- (2011) Anthony H. Schapira et al. MOVEMENT DISORDERS
- Milestones in Parkinson's disease therapeutics
- (2011) Olivier Rascol et al. MOVEMENT DISORDERS
- Milestones in Parkinson's disease-Clinical and pathologic features
- (2011) Glenda Halliday et al. MOVEMENT DISORDERS
- Milestones in research on the pathophysiology of Parkinson's disease
- (2011) Thomas Wichmann et al. MOVEMENT DISORDERS
- Priorities in Parkinson's disease research
- (2011) Wassilios G. Meissner et al. NATURE REVIEWS DRUG DISCOVERY
- 6 2* and 4 2* Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson's Disease
- (2011) M. Quik et al. PHARMACOLOGICAL REVIEWS
- Can nicotine be used medicinally in Parkinson’s disease?
- (2011) Claire Thiriez et al. Expert Review of Clinical Pharmacology
- Functional models of Parkinson's disease: A valuable tool in the development of novel therapies
- (2010) Peter Jenner ANNALS OF NEUROLOGY
- Allosteric Receptors: From Electric Organ to Cognition
- (2010) Jean-Pierre Changeux Annual Review of Pharmacology and Toxicology
- Gene Therapy in Parkinsonʼs Disease
- (2010) Li Rebekah Feng et al. CNS DRUGS
- Nicotinic Acetylcholine Receptors in the Mesolimbic Pathway: Primary Role of Ventral Tegmental Area 6 2* Receptors in Mediating Systemic Nicotine Effects on Dopamine Release, Locomotion, and Reinforcement
- (2010) C. Gotti et al. JOURNAL OF NEUROSCIENCE
- Nicotinic Receptor-Mediated Reduction in L-DOPA-Induced Dyskinesias May Occur via Desensitization
- (2010) T. Bordia et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- 4 2 Nicotinic Receptors Partially Mediate Anti-Inflammatory Effects through Janus Kinase 2-Signal Transducer and Activator of Transcription 3 but Not Calcium or cAMP Signaling
- (2010) V. Hosur et al. MOLECULAR PHARMACOLOGY
- Advances in environmental epidemiology
- (2010) Caroline M. Tanner MOVEMENT DISORDERS
- Voluptuary habits and clinical subtypes of Parkinson's disease: The FRAGAMP case-control study
- (2010) Alessandra Nicoletti et al. MOVEMENT DISORDERS
- Parkinson's disease: 10 years of progress, 1997-2007
- (2010) Stanley Fahn MOVEMENT DISORDERS
- Missing pieces in the Parkinson's disease puzzle
- (2010) Jose A Obeso et al. NATURE MEDICINE
- Smoking duration, intensity, and risk of Parkinson disease
- (2010) H. Chen et al. NEUROLOGY
- Genetic Animal Models of Parkinson's Disease
- (2010) Ted M. Dawson et al. NEURON
- Nicotine increases the expression of neurotrophin receptor tyrosine kinase receptor A in basal forebrain cholinergic neurons
- (2010) E. Formaggio et al. NEUROSCIENCE
- Nicotine Addiction
- (2010) Neal L. Benowitz NEW ENGLAND JOURNAL OF MEDICINE
- Progression of Parkinson's Disease Pathology Is Reproduced by Intragastric Administration of Rotenone in Mice
- (2010) Francisco Pan-Montojo et al. PLoS One
- Rasagiline: A novel anti-Parkinsonian monoamine oxidase-B inhibitor with neuroprotective activity
- (2010) Orly Weinreb et al. PROGRESS IN NEUROBIOLOGY
- Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature
- (2010) Noah S. Philip et al. PSYCHOPHARMACOLOGY
- Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis
- (2010) Yann S. Mineur et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Alpha9 nicotinic acetylcholine receptors and the treatment of pain
- (2009) J. Michael McIntosh et al. BIOCHEMICAL PHARMACOLOGY
- Multiple roles for nicotine in Parkinson's disease
- (2009) Maryka Quik et al. BIOCHEMICAL PHARMACOLOGY
- Nicotinic actions on neuronal networks for cognition: General principles and long-term consequences
- (2009) Rogier B. Poorthuis et al. BIOCHEMICAL PHARMACOLOGY
- nAChR agonist-induced cognition enhancement: Integration of cognitive and neuronal mechanisms
- (2009) Martin Sarter et al. BIOCHEMICAL PHARMACOLOGY
- Nicotinic Receptor-Mediated Neuroprotection in Neurodegenerative Disease Models
- (2009) Shun Shimohama BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Mecamylamine – a nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disorders
- (2009) Ingrid Bacher et al. EXPERT OPINION ON PHARMACOTHERAPY
- Cholinergic control of inflammation
- (2009) M. Rosas-Ballina et al. JOURNAL OF INTERNAL MEDICINE
- Nicotine is neuroprotective when administered before but not after nigrostriatal damage in rats and monkeys
- (2009) Luping Z. Huang et al. JOURNAL OF NEUROCHEMISTRY
- Combination therapy with Coenzyme Q10and creatine produces additive neuroprotective effects in models of Parkinson’s and Huntington’s Diseases
- (2009) Lichuan Yang et al. JOURNAL OF NEUROCHEMISTRY
- Aging-dependent changes of microglial cells and their relevance for neurodegenerative disorders
- (2009) Rommy von Bernhardi et al. JOURNAL OF NEUROCHEMISTRY
- Neuroinflammation in Parkinson's disease: a target for neuroprotection?
- (2009) Etienne C Hirsch et al. LANCET NEUROLOGY
- Rodent models of treatment-induced motor complications in Parkinson's disease
- (2009) M. Angela Cenci et al. PARKINSONISM & RELATED DISORDERS
- Nicotinic Acetylcholine Receptor Signalling: Roles in Alzheimer's Disease and Amyloid Neuroprotection
- (2009) S. D. Buckingham et al. PHARMACOLOGICAL REVIEWS
- Mammalian Nicotinic Acetylcholine Receptors: From Structure to Function
- (2009) Edson X. Albuquerque et al. PHYSIOLOGICAL REVIEWS
- T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening?
- (2009) Stanley H. Appel et al. TRENDS IN IMMUNOLOGY
- Serum Urate as a Predictor of Clinical and Radiographic Progression in Parkinson Disease
- (2008) Michael A. Schwarzschild ARCHIVES OF NEUROLOGY
- Progress in neuroprotection in Parkinson’s disease
- (2008) A. H. V. Schapira EUROPEAN JOURNAL OF NEUROLOGY
- Continuous and Intermittent Nicotine Treatment Reduces L-3,4-Dihydroxyphenylalanine (L-DOPA)-Induced Dyskinesias in a Rat Model of Parkinson's Disease
- (2008) T. Bordia et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Nicotine and Parkinson's disease: Implications for therapy
- (2008) Maryka Quik et al. MOVEMENT DISORDERS
- The prodromal phase of sporadic Parkinson's disease: Does it exist and if so how long is it?
- (2008) Christopher H. Hawkes MOVEMENT DISORDERS
- Diversity of vertebrate nicotinic acetylcholine receptors
- (2008) Neil S. Millar et al. NEUROPHARMACOLOGY
- Targeting nicotinic receptor antagonists as novel pharmacotherapies for tobacco dependence and relapse
- (2008) Linda P Dwoskin et al. NEUROPSYCHOPHARMACOLOGY
- Protection against Parkinson’s disease progression: Clinical experience
- (2008) Peter A. LeWitt et al. Neurotherapeutics
- Neurochemical pathways involved in the protective effects of nicotine and ethanol in preventing the development of Parkinson's disease: Potential targets for the development of new therapeutic agents
- (2008) Roberta J. Ward et al. PROGRESS IN NEUROBIOLOGY
- Neurobiology and treatment of Parkinson's disease
- (2008) Anthony H.V. Schapira TRENDS IN PHARMACOLOGICAL SCIENCES
- Encapsulated cell biodelivery of GDNF: A novel clinical strategy for neuroprotection and neuroregeneration in Parkinson's disease?
- (2007) Olle Lindvall et al. EXPERIMENTAL NEUROLOGY
- Neuroprotection via nAChRs: the role of nAChRs in neurodegenerative disorders such as Alzheimer's and Parkinson's disease
- (2007) Marina et al. Frontiers in Bioscience-Landmark
- Nonmotor symptoms as presenting complaints in Parkinson's disease: A clinicopathological study
- (2007) Sean S. O'Sullivan et al. MOVEMENT DISORDERS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started